Consistent with previous reports, no mutation was common in all 3 patients (14), except one gene, TP53. Mutational signature 3 (associated with BRCA1 mutation) and mutational signature 13 were enriched in all tumor samples from all patients (Fig. 1B). This evidence concerns the gene TP53 and neoplasm.